Use of polysaccharides in acute peripheral neuropathies

Details Use of polysaccharides in acute peripheral neuropathies Use of polysaccharides in acute peripheral neuropathies

1993-07-21

1997-02-25

Mullis, Jeffrey C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 56, A61K 31715, A61K 31725

Patent

active

056058918

ABSTRACT:
Polysaccharides and more in particular glycosaminoglycans, their mixtures, fractions and derivatives thereof are effective agents in the therapy of acute peripheral neuropathies of traumatic and ischemic origin and in the therapy of acute peripheral neuropathies of toxic origin.

REFERENCES:
patent: 5236910 (1993-08-01), Egidio et al.
patent: 5356895 (1994-10-01), Ulrich et al.
Fowler, Electromyogr. clin. Neurophysiol, "Neuropathy in Mucopolysaccharidosis Type 3", 1974, 14, 29-34.
Battaggia, Pain, "Effects of Hyaluronidase in Patients with Spinal Arachnoi Ditis and Peripheral Entrapment Neuropathies", Aug. 1987.
Greenhall, Neuropathol. Appl. Neurobiol, "Clinical and Neuropathological Observations in a Controlled Trial of Low Molecular Weight Dextran (LMD) in acute cerebral infarction", 1975, Jan. 1, (108).

Affiliated with

Also associated with

Rating

Use of polysaccharides in acute peripheral neuropathies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of polysaccharides in acute peripheral neuropathies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of polysaccharides in acute peripheral neuropathies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1974081